See leaflet
Lipecelte®
trabectedin
Indications
- Adult patients with advanced soft tissue sarcoma (STS) who have failed treatment with anthracyclines and ifosfamide, or who are not candidates for such products
- Patients with platinum-sensitive recurrent ovarian cancer, in combination with pegylated liposomal doxorubicin (PLD).
Presentations
- LIPECELTE® is supplied in a single-dose glass vial containing 1 mg of trabectedin
- LIPECELTE® is supplied in a single-dose glass vial containing 1 mg of trabectedin